Evidence map›Paper›PMID 31522588›Full record

ArticleCell cycle (Georgetown, Tex.)2019

Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.

Ling Liu, Xin Yang, Nian-Feng Li, Ling Lin, Hui Luo

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. MiR-7 in Cancer Development.Biomedicines · 2021
    Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Role of microRNA-7 in liver diseases: a comprehensive review of the mechanisms and therapeutic applications.Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2020
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ling LiuDepartment of General Surgery, Xiangya Hospital, Central South University , Changsha , P.R.China.
Xin YangDepartment of General Surgery, The Second Xiangya Hospital, Central South University , Changsha , P.R.China.
Nian-Feng LiDepartment of General Surgery, Xiangya Hospital, Central South University , Changsha , P.R.China.
Ling LinDepartment of General Surgery, Xiangya Hospital, Central South University , Changsha , P.R.China.
Hui LuoDepartment of General Surgery, Xiangya Hospital, Central South University , Changsha , P.R.China.
Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsApoptosisCarcinoma, HepatocellularCell Line, TumorCell MovementCell ProliferationFocal Adhesion Kinase 1Gene Expression Regulation, NeoplasticGene Knockdown TechniquesHumansKruppel-Like Factor 4LiverLiver NeoplasmsMiceMice, Inbred BALB CMice, NudeFocal Adhesion Kinase 1KLF4 protein, humanKlf4 protein, mouseKruppel-Like Factor 4MicroRNAsMIRN7-1 microRNA, humanPTK2 protein, humanRNA, CircularCircular RNAhepatocellular carcinomamicroRNA-7

Identifiers

PMID31522588
PMCPMC6791692
OpenAlexW2974017097

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.